Approach to congenital heart diseases (acyanotic): Clinical sciences

Last updated: September 12, 2024

Approach to congenital heart diseases (acyanotic): Clinical sciences

Watch later

Watch later

Nernst equation
Cytoskeleton and intracellular motility
Cell signaling pathways
Resting membrane potential
Gene regulation
Epigenetics
Nuclear structure
DNA structure
Transcription of DNA
Amino acids and protein folding
Necrosis and apoptosis
Endometrial hyperplasia and cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Metaplasia and dysplasia
Oral cancer
Testicular cancer
Lung cancer
Asthma
Atrial septal defect
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Acute respiratory distress syndrome
Angina pectoris
Aortic valve disease
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Coarctation of the aorta
Deep vein thrombosis
Emphysema
Endocarditis
Gas exchange in the lungs, blood and tissues
Heart failure
Mitral valve disease
Cor pulmonale
Heart failure: Pathology review
Myocarditis
Diabetes mellitus: Pathology review
Adrenocorticotropic hormone
Chlamydia trachomatis
Cortisol
Abnormal uterine bleeding: Clinical
Cushing syndrome
Endometriosis
Glucagon
Glucocorticoids
Herpes simplex virus
HIV (AIDS)
Hypothyroidism: Pathology review
Hypothyroidism
Insulin
Neisseria gonorrhoeae
Pelvic inflammatory disease
Polycystic ovary syndrome
Benign prostatic hyperplasia
Thyroid hormones
Testosterone
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Primary adrenal insufficiency
Hyperthyroidism: Pathology review
Chronic leukemia
Anemia of chronic disease
Hemophilia
Heparin-induced thrombocytopenia
Hypocalcemia
Hypermagnesemia
Hypokalemia
Hypomagnesemia
Inflammation
Innate immune system
Complement system
Iron deficiency anemia
Leukemias: Pathology review
Platelet disorders: Pathology review
Sickle cell disease (NORD)
Type IV hypersensitivity
Vaccinations
Acute pyelonephritis
Celiac disease
Cirrhosis
Congenital disorders: Clinical
Appendicitis
Autoimmune hepatitis
Bowel obstruction
Chronic cholecystitis
Chronic pyelonephritis
Crohn disease
Gastroesophageal reflux disease (GERD)
Nephrotic syndromes: Pathology review
Irritable bowel syndrome
Lower urinary tract infection
Biliary colic
Peptic ulcer
Renal failure: Pathology review
Urinary tract infections: Pathology review
Viral hepatitis
Pancreatitis: Pathology review
Alcohol-associated liver disease
Ulcerative colitis
Medullary cystic kidney disease
Small bowel ischemia and infarction
Chronic kidney disease
Acute cholecystitis
Skin cancer
Autosomal trisomies: Pathology review
Selective permeability of the cell membrane
Free radicals and cellular injury
Pericarditis and pericardial effusion
Peripheral artery disease
Cauda equina syndrome
Cranial nerves
Dementia: Pathology review
Arteriovenous malformation
Bipolar and related disorders
Seizures and epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Major depressive disorder
Meningitis
Migraine
Multiple sclerosis
Myasthenia gravis
Panic disorder
Parkinson disease
Alzheimer disease
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Coagulation disorders: Pathology review
Factor V Leiden
Hodgkin lymphoma
Disseminated intravascular coagulation
Non-Hodgkin lymphoma
Introduction to the immune system
Acute pancreatitis
Approach to congenital heart diseases (acyanotic): Clinical sciences
Acne vulgaris
Atopic dermatitis
Back pain: Pathology review
Bone disorders: Pathology review
Burns
Osteoarthritis
Osteoporosis
Paget disease of bone
Psoriasis
Rheumatoid arthritis
Varicella zoster virus
Introduction to pharmacology
Drug administration and dosing regimens
Enzyme function
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Agonist, partial agonist and antagonist
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid antagonists
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Role of Vitamin K in coagulation
Loop diuretics
Miscellaneous lipid-lowering medications
Potassium sparing diuretics
Adrenergic antagonists: Alpha blockers
Calcium channel blockers
Adrenergic antagonists: Beta blockers
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class I antiarrhythmics: Sodium channel blockers
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Anti-mite and louse medications
Antimalarials
Hepatitis medications
Anthelmintic medications
Integrase and entry inhibitors
Antimetabolites: Sulfonamides and trimethoprim
Azoles
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Echinocandins
Herpesvirus medications
Mechanisms of antibiotic resistance
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Neuraminidase inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Antihistamines for allergies
Miscellaneous antifungal medications
Antituberculosis medications
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
PDE5 inhibitors
Progestins and antiprogestins
Uterine stimulants and relaxants
Acid reducing medications
Antidiarrheals
Laxatives and cathartics
Non-corticosteroid immunosuppressants and immunotherapies
Hyperthyroidism medications
Hypoglycemics: Insulin secretagogues
Hypothyroidism medications
Insulins
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Sympatholytics: Alpha-2 agonists
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Atypical antipsychotics
Atypical antidepressants
Typical antipsychotics
Lithium
Monoamine oxidase inhibitors
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Anti-parkinson medications
Tricyclic antidepressants
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Migraine medications
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Antigout medications
Folate (Vitamin B9) deficiency
Vitamin D
Fat-soluble vitamin deficiency and toxicity: Pathology review
Approach to viral exanthems (pediatrics): Clinical sciences
Mumps virus
Measles virus
Rubella virus
Bordetella pertussis (Whooping cough)
Poliovirus

Decision-Making Tree

Transcript

Watch video only

Acyanotic congenital heart disease refers to structural heart lesions that do not cause significant blood oxygen desaturation or cyanosis. It's crucial to identify acyanotic congenital heart lesions promptly in order to treat any complications, like shock or heart failure.

If a pediatric patient presents with chief concern suggesting acyanotic congenital heart disease, first perform an ABCDE assessment. If the patient is unstable, stabilize the airway, breathing, and circulation. You may even need to intubate and mechanically ventilate your patient. Next, obtain IV access, and consider starting IV fluids.

Begin continuous vital sign monitoring, including blood pressure, heart rate, and oxygen saturation. Finally, if needed, provide supplemental oxygen. Once you’ve initiated acute management, perform a focused history and physical examination.

Then obtain pulse oximetry measurements in the right hand, which measures preductal saturation; and the feet, which measures post-ductal saturations. These measurements allow you to compare oxygenation of the systemic circulation before and after the ductus arteriosus inserts into the aorta.

Unstable infants often present around 2 weeks of age, as the ductus arteriosus begins to close, with symptoms like poor feeding, lethargy, and respiratory distress. Additionally, there may have been a prenatal ultrasound showing a heart defect.

Exam findings include signs of shock, like gray, cool, mottled skin. You might also find weak pulses in all 4 extremities, or the femoral pulses might be absent.

On auscultation, many patients will have an audible S3, and some will have a murmur. On pulse oximetry, preductal saturations may be higher than postductal saturations.

This suggests that deoxygenated blood is being shunted from the pulmonary artery to the aorta, through an open ductus arteriosus, and the lower extremities might appear cyanotic.

This is called differential cyanosis and suggests the presence of critical congenital heart disease.

These findings should immediately make you consider lesions associated with critical left ventricular outflow tract obstruction, such as critical aortic stenosis or critical coarctation of the aorta.

Start an infusion of prostaglandin E1, or PGE1, to keep the ductus arteriosus open and restore systemic circulation.

Here’s a high-yield fact! PGE1 provides a life-saving bridge to surgery in newborns with ductal-dependent lesions by promoting systemic and pulmonary mixing or by improving systemic or pulmonary circulation. Avoid giving PGE1 to infants with increased pulmonary blood flow, since it can exacerbate pulmonary overcirculation.

Now that you’ve started PGE1, order an echocardiogram or echo to evaluate the heart and great vessels.

If echo reveals severe aortic valve stenosis, with or without left ventricular hypertrophy, diagnose critical aortic stenosis.

On the other hand, echo may show a hypoplastic aortic arch, possibly with abnormal aortic valve morphology and post-stenotic dilatation.

In some cases, it may demonstrate complete discontinuity of the arch between the ascending and descending aorta, indicating an interrupted aortic arch, which is the most severe form of coarctation. In either case, diagnose critical coarctation of the aorta.

Here’s a clinical pearl! Critical left ventricular outflow obstruction is commonly mistaken for sepsis, since both conditions can present with shock and similar clinical manifestations. Remember to check femoral pulses, and consider left ventricular outflow obstruction whenever a newborn presents with shock.

Now that we’ve discussed unstable patients, let’s go back and discuss stable ones. Start by obtaining a focused history and physical exam, and pulse oximetry measurements in the right hand and feet.

History usually reveals abnormal prenatal ultrasound findings suggesting a congenital heart lesion. Depending on the lesion, many patients are asymptomatic, but others may experience poor weight gain, difficulty feeding, or fatigue.

As for the physical exam, your patient will not appear cyanotic, but you may detect a heart murmur and notice signs of heart failure, like tachypnea and hepatomegaly.

Finally, pulse oximetry will reveal oxygen saturations above 90% in the right hand and the feet. With these findings, consider acyanotic congenital heart disease. Next order an echo, and assess the pulmonary blood flow.

First let's discuss patients with normal or decreased pulmonary blood flow.

If it’s normal or decreased, consider obstructive lesions like non-critical coarctation of the aorta, aortic stenosis, and pulmonary stenosis.

Let’s start with non-critical coarctation of the aorta, which is frequently identified in childhood or adolescence. Symptoms are often absent, but some children experience epistaxis or leg pain with exercise.

Physical exam commonly reveals upper extremity hypertension, with a blood pressure gradient of more than 20 mm mercury between the upper and lower extremities.

Additionally, you’ll probably find diminished lower extremity pulses with a radial-femoral delay, and there might be a harsh systolic murmur at the left sternal border that radiates to the back.

Echo typically reveals juxtaductal coarctation of the aorta, often with left ventricular hypertrophy, which confirms non-critical coarctation of the aorta.

Next up is aortic stenosis. Patients with mild-to-moderate stenosis are usually asymptomatic, while those with severe stenosis can develop exertional chest pain, dyspnea, or fatigue.

Physical exam reveals a systolic murmur at the right upper sternal border that is softer with a Valsalva maneuver. There could also be a palpable thrill or a systolic ejection click.

Echo will demonstrate valvular, subvalvular, or supravalvular aortic stenosis and you may notice a bicuspid aortic valve as well as left ventricular hypertrophy. These findings confirm aortic stenosis.

Here’s another clinical pearl! Supravalvular aortic stenosis is commonly seen in association with Williams syndrome, so be sure to look for phenotypic features of this condition, including a full face, broad forehead, rounded cheeks, and a depressed nasal bridge with anteversion of the nares.

Finally, let’s discuss pulmonary stenosis. If the stenosis is mild or moderate, patients are usually asymptomatic, but if it’s severe, patients may report fatigue, exertional dyspnea, or even syncope.

Sources

  1. "Updated Strategies for Pulse Oximetry Screening for Critical Congenital Heart Disease" Pediatrics (2020)
  2. "Health Care Supervision for Children With Williams Syndrome" Pediatrics (2020)
  3. "The Care of Children With Congenital Heart Disease in Their Primary Medical Home" Pediatrics (2017)
  4. "Nelson Textbook of Pediatrics, 21st ed." Elsevier (2020)
  5. "Congenital Heart Disease" Pediatr Rev (2017)
  6. "Presentation of congenital heart disease in the neonate and young infant" Pediatr Rev (2007)